കീമോതെറാപ്പി വിമുക്ത APML ബ്ലഡ് കാൻസർ ചികിത്സ - Patient experience | Meitra Hospital

Поделиться
HTML-код
  • Опубликовано: 30 сен 2024
  • കീമോതെറാപ്പി വിമുക്ത APML ബ്ലഡ് കാൻസർ ചികിത്സ - Patient experience
    Acute promyelocytic leukaemia (APML) is a rare sub-type of acute myeloid leukaemia (AML) and is sometimes referred to as AML M31. APML accounts for only 10% of all AML diagnoses.
    In APML, immature abnormal neutrophils (a type of white blood cell) known as promyelocytes accumulate in the bone marrow. These immature cells are unable to mature and function like healthy mature white cells. The accumulation of these immature cells in the marrow inhibits normal cell production, which results in lower numbers of blood cells circulating the body.
    APML is most commonly associated with a swapping over (translocation) of chromosomes 15 and 17. This causes parts of a gene from each of these chromosomes to join and create a fusion gene called PML/RARA. In some cases, other chromosomes may translocate and cause a variant APML, but this is quite rare.

Комментарии • 2

  • @godislove2502
    @godislove2502 2 месяца назад

    Kindly mention total expense as my mother is suffering with same condition right now

  • @Anoop-ht3cq
    @Anoop-ht3cq 2 месяца назад

    Etra Expense aayi e treatmentinu ente ammakk ethanu
    please rply